Related Experiment Video
Updated: Oct 6, 2025

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
IL-1/IL-1R Signaling in Head and Neck Cancer
Sven E Niklander1, Craig Murdoch2, Keith D Hunter2,3
1Unidad de Patología y Medicina Oral, Facultad de Odontologia, Universidad Andres Bello, Viña del Mar, Chile.
Abstract:
Decades ago, the study of cancer biology was mainly focused on the tumor itself, paying little attention to the tumor microenvironment (TME). Currently, it is well recognized that the TME plays a vital role in cancer development and progression, with emerging treatment strategies focusing on different components of the TME, including tumoral cells, blood vessels, fibroblasts, senescent cells, inflammatory cells, inflammatory factors, among others. There is a well-accepted relationship between chronic inflammation and cancer development. Interleukin-1 (IL-1), a potent pro-inflammatory cytokine commonly found at tumor sites, is considered one of the most important inflammatory factors in cancer, and has been related with carcinogenesis, tumor growth and metastasis. Increasing evidence has linked development of head and neck squamous cell carcinoma (HNSCC) with chronic inflammation, and particularly, with IL-1 signaling. This review focuses on the most important members of the IL-1 family, with emphasis on how their aberrant expression can promote HNSCC development and metastasis, highlighting possible clinical applications.
Insights
The tumor microenvironment influences cancer. Interleukin-1 (IL-1) signaling is linked to head and neck squamous cell carcinoma (HNSCC) development and metastasis, suggesting potential clinical applications.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- The tumor microenvironment (TME) is crucial for cancer progression.
- Chronic inflammation is linked to cancer development.
- Interleukin-1 (IL-1) is a key pro-inflammatory cytokine implicated in cancer.
Purpose of the Study:
- To review the role of Interleukin-1 (IL-1) family members in head and neck squamous cell carcinoma (HNSCC).
- To highlight how aberrant IL-1 signaling promotes HNSCC development and metastasis.
- To discuss potential clinical applications targeting IL-1 in HNSCC.
Main Methods:
- Literature review focusing on IL-1 family in HNSCC.
- Analysis of existing evidence linking inflammation and HNSCC.
- Examination of IL-1 signaling pathways in cancer progression.
Main Results:
- IL-1 family members are implicated in HNSCC carcinogenesis, growth, and metastasis.
- Aberrant expression of IL-1 signaling components promotes HNSCC.
- IL-1 plays a significant role in the inflammatory TME of HNSCC.
Conclusions:
- IL-1 signaling is a critical factor in HNSCC development and progression.
- Targeting IL-1 pathways may offer novel therapeutic strategies for HNSCC.
- Understanding IL-1's role in the TME is vital for HNSCC treatment.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Intracellular Signaling Affects Focal Adhesions
Some...

